"Company","Parent Company","Penalty Amount","Subtraction From Penalty","Penalty Amount Adjusted For Eliminating Multiple Counting","Penalty Year","Penalty Date","Offense Group","Primary Offense","Secondary Offense","Description","Level of Government","Action Type","Agency","Civil/Criminal","Prosecution Agreement","Court","Case ID","Private Litigation Case Title","Lawsuit Resolution","Facility State","City","Address","Zip","NAICS Code","NAICS Translation","HQ Country of Parent","HQ State of Parent","Ownership Structure","Parent Company Stock Ticker","Major Industry of Parent","Specific Industry of Parent","Info Source","Notes"
"Taro Pharmaceutical Industries","Taro Pharmaceutical Industries","$5,000,000","$0","$5,000,000","2013","20131118","government-contracting-related offenses","False Claims Act and related","","The Louisiana Attorney General's Office announced that it had obtained a total of $88 million in settlements from 25 pharmaceutical companies to resolve allegations they overcharged the state's Medicaid program.","state","agency action","Louisiana Attorney General","civil","","","","","","Louisiana","","","","","","Israel","","publicly traded","TARO","pharmaceuticals","pharmaceuticals","https://web.archive.org/web/20131206104321/http://www.ag.state.la.us/Article.aspx?articleID=788&catID=2",""
"Taro Pharmaceuticals USA, Inc.","Taro Pharmaceutical Industries","$8,750,000","$0","$8,750,000","2014","20140811","government-contracting-related offenses","False Claims Act and related","","Falsification of wholesale drug price reporting. Federal government shared in the settlement. Penalty amount listed here is state portion only.","state","agency action","Texas Attorney General","civil","","","","","","Texas","","","","","","Israel","","publicly traded","TARO","pharmaceuticals","pharmaceuticals","Attorney General Abbott Recovers $19.5 Million for State of Texas, U.S., Targeted News Service, August 11, 2014 (via Nexis).",""
"Taro Pharmaceuticals USA, Inc.","Taro Pharmaceutical Industries","$213,200,000","$0","$213,200,000","2021","20211001","government-contracting-related offenses","False Claims Act and related","price-fixing or anti-competitive practices","Three generic pharmaceutical manufacturers, Taro Pharmaceuticals USA, Inc., Sandoz Inc. and Apotex Corporation, agreed to pay a total of $447.2 million to resolve alleged violations of the False Claims Act arising from conspiracies to fix the price of various generic drugs.","federal","agency action","Justice Department Civil Division","civil","","","","","","","","","","","","Israel","","publicly traded","TARO","pharmaceuticals","pharmaceuticals","https://www.justice.gov/opa/pr/pharmaceutical-companies-pay-over-400-million-resolve-alleged-false-claims-act-liability",""
"TARO PHARMACEUTICALS USA, INC.","Taro Pharmaceutical Industries","$18,565","$0","$18,565","2019","20190206","safety-related offenses","workplace safety or health violation","","","federal","agency action","Occupational Safety & Health Administration","civil","","","","","","New Jersey","CRANBURY","1 COMMERCE DR.","08512","493110","493110: General Warehousing and Storage","Israel","","publicly traded","TARO","pharmaceuticals","pharmaceuticals","Extracted from a download of OSHA's Enforcment Data downloaded on 3/02/2022, available at https://enforcedata.dol.gov/views/data_catalogs.php",""
